| Brooks Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 533543 |
NSE Symbol : BROOKS |
P/E(TTM) : 42.93 |
|
ISIN Demat : INE650L01011 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.55 |
|
Book Value(₹) : 41.02 |
Market Cap(₹Cr) : 196.01 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 22.96 | 20.21 | 16.57 | 23.45 | 25.51 | 23.32 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 22.96 | 20.21 | 16.57 | 23.45 | 25.51 | 23.32 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.18 | 0.44 | 0.13 | 0.39 | 0.22 | 0.62 |
| Total Income | 23.14 | 20.65 | 16.69 | 23.84 | 25.73 | 23.94 |
| Total Expenditure | 21.10 | 19.53 | 15.83 | 20.93 | 22.39 | 21.74 |
| PBIDT | 2.04 | 1.12 | 0.86 | 2.91 | 3.34 | 2.20 |
| Interest | 0.21 | 0.09 | 0.16 | 0.28 | 0.30 | 0.26 |
| PBDT | 1.83 | 1.03 | 0.70 | 2.63 | 3.04 | 1.94 |
| Depreciation | 0.42 | 0.41 | 0.39 | 0.39 | 0.39 | 0.39 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.42 | 0.61 | 0.30 | 2.24 | 2.65 | 1.37 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.42 | 0.61 | 0.30 | 2.24 | 2.65 | 1.37 |
| EPS (Unit Curr.) | 0.48 | 0.21 | 0.10 | 0.76 | 0.90 | 0.51 |
| EPS (Adj) (Unit Curr.) | 0.48 | 0.21 | 0.10 | 0.76 | 0.90 | 0.51 |
| Calculated EPS (Unit Curr.) | 0.48 | 0.21 | 0.10 | 0.76 | 0.90 | 0.47 |
| Calculated EPS (Adj) (Unit Curr.) | 0.48 | 0.21 | 0.10 | 0.76 | 0.90 | 0.47 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.93 | 0.83 | 0.41 | 3.04 | 3.60 | 1.86 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.93 | 0.83 | 0.41 | 3.04 | 3.60 | 1.86 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 29.46 | 29.46 | 29.46 | 29.46 | 29.46 | 29.46 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.89 | 5.54 | 5.19 | 12.41 | 13.09 | 9.43 |
| PBDTM(%) | 7.97 | 5.10 | 4.22 | 11.22 | 11.92 | 8.32 |
| PATM(%) | 6.18 | 3.02 | 1.81 | 9.55 | 10.39 | 5.87 |
